Public Advisory - Equate (lemon flavour), Personnelle (lemon flavour) and Life Brand (lemon and cherry flavours) Magnesium citrate oral solution saline laxatives recalled due to potential microbial contamination
OTTAWA, ON, July 24, 2022 /CNW/ -
Summary
Product: Equate (lemon flavour), Personnelle (lemon flavour) and Life Brand (lemon and cherry flavours) Magnesium citrate oral solution saline laxative, lemon and cherry flavours (NPN 80015316)
Issue: Health product ? product safety
What to do: Stop using the recalled product. Speak to a health care professional if you have taken this product and have health concerns.
Health Canada is advising that all lots of Equate (lemon flavour), Life Brand (lemon and cherry flavours) and Personnelle (lemon flavour) Magnesium citrate oral solution saline laxative (NPN 80015316) are being recalled by the importer, Shandex Sales Group Ltd. (Shandex Group), due to the possibility of microbial contamination. The company is recalling the products as a precaution in light of a recall in the United States (U.S.) of similar products that are manufactured at the same site.
Magnesium citrate oral solution is used as a laxative for relief of occasional constipation. The product is indicated for use in adults and children two years of age and older.
Microbial testing of the products recalled in the U.S. identified the presence of Gluconacetobacter liquefaciens. Ingesting contaminated product may result in symptoms including abdominal discomfort or pain, diarrhea, nausea and vomiting. Children, pregnant women, the elderly and people with a weakened immune system may be more susceptible to serious adverse effects from microbial contamination.
The Department is monitoring the company's recall and will inform Canadians if any new health risks are identified.
What you should do
Stop using the recalled product.
Contact your health care practitioner if you have used this product and have concerns about your health.
Contact the importer, Shandex Sales Group Ltd. by calling 1-905-420-7407, or by email at [email protected], if you have questions about this recall.
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...